Literature DB >> 11836847

Apoptosis and bcl-2 expression in irradiated lungs and the effect of pentoxifylline.

J Osterreicher1, M Králik, L Navrátil, J Vávrová, J Skopek, J Knízek, A Macela.   

Abstract

We measured number of bcl-2, apoptotic, neutrophil, and surfactant apoprotein D (SP-D) positive cells in irradiated rat lungs during different time points after the sublethal whole-thorax irradiation of rats. We also investigated the influence of pentoxifylline (PTX) therapy on these markers. Wistar rats were given 15 Gy thoracic irradiation and PTX (35 mg/kg) twice a week. Animals were examined histologically and imunohistochemically at intervals from 1-12 weeks. In non-treated rats compared with treated rats, bcl-2 expression was significantly inhibited from 4 weeks after irradiation. A higher apoptosis presence in non-treated rats from 4 weeks was found and apoptosis development in PTX-treated animals was delayed and started 8 weeks after irradiation. Similar differences were measured during neutrophil granulocytes examination. Neutrophil penetration in non-treated rats was found 5 weeks after irradiation in contrast to the RP onset of PTX-treated animals 8 weeks after irradiation. The number of SP-D positive cells in non-treated rats observed until 5 weeks after irradiation was higher than in the control group. PTX-treated animals expressed higher number of SP-D positive cells during the whole experiment than the control group. We suggest that apoptosis is linked to neutrophil granulocyte actions during the RP onset and that PTX-therapy causes diminished inflammation development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11836847

Source DB:  PubMed          Journal:  Acta Medica (Hradec Kralove)        ISSN: 1211-4286


  1 in total

1.  Vascular endothelium derived endothelin-1 is required for normal heart function after chronic pressure overload in mice.

Authors:  Susi Heiden; Nicolas Vignon-Zellweger; Shigeru Masuda; Keiko Yagi; Kazuhiko Nakayama; Masashi Yanagisawa; Noriaki Emoto
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.